ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,676.35
-1.81%
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs Yen
158.68
0.34%
Brent Oil
83.84
-0.59%
Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. イギリス
  5. LSE
  6. Alligator Bioscience Ab (0RK9)

  7. Alligator Bioscience Ab (0RK9) ニュース

0RK9

Alligator Bioscience Ab (0RK9)

Alligator Bioscience Ab
から:
次の項目別のソート:
 Showing the most relevant articles for your search:LSE:0RK9
日付受信時刻ニュースソース見出しコード企業名
2020/12/3021 : 54PR Newswire (US)Alligator Bioscience publishes prospectus in connection with forthcoming rights issueLSE:0RK9Alligator Bioscience Ab
2020/12/2917 : 25PR Newswire (US)Alligator Bioscience recruits new Chief Medical OfficerLSE:0RK9Alligator Bioscience Ab
2020/12/2917 : 23PR Newswire (US)Alligator Bioscience recruits new Chief Medical OfficerLSE:0RK9Alligator Bioscience Ab
2020/12/2819 : 26PR Newswire (US)Alligator Bioscience submits CTA for the mitazalimab Phase II study OPTIMIZE-1LSE:0RK9Alligator Bioscience Ab
2020/12/2819 : 25PR Newswire (US)Alligator Bioscience submits CTA for the mitazalimab Phase II study OPTIMIZE-1LSE:0RK9Alligator Bioscience Ab
2020/12/1016 : 53PR Newswire (US)Alligator Bioscience launches ALLIGATOR-FAB™ - a novel human antibody libraryLSE:0RK9Alligator Bioscience Ab
2020/12/1016 : 51PR Newswire (US)Alligator Bioscience launches ALLIGATOR-FAB™ - a novel human antibody libraryLSE:0RK9Alligator Bioscience Ab
2020/12/0417 : 20PR Newswire (US)Approved IND for Alligator Bioscience's CD40-targeting antibody mitazalimabLSE:0RK9Alligator Bioscience Ab
2020/12/0417 : 18PR Newswire (US)Approved IND for Alligator Bioscience's CD40-targeting antibody mitazalimabLSE:0RK9Alligator Bioscience Ab
2020/11/1622 : 18PR Newswire (US)Aptevo Therapeutics and Alligator Bioscience advancing the bispecific 4-1BBx5T4 antibody ALG.APV-527 into Phase I clinical de...LSE:0RK9Alligator Bioscience Ab
2020/11/1622 : 16PR Newswire (US)Aptevo Therapeutics and Alligator Bioscience advancing the bispecific 4-1BBx5T4 antibody ALG.APV-527 into Phase I clinical de...LSE:0RK9Alligator Bioscience Ab
2020/11/0922 : 15PR Newswire (US)Alligator Bioscience presents at the SITC 35th Annual MeetingLSE:0RK9Alligator Bioscience Ab
2020/11/0922 : 12PR Newswire (US)Alligator Bioscience presents at the SITC 35th Annual MeetingLSE:0RK9Alligator Bioscience Ab
2020/11/0516 : 56PR Newswire (US)Alligator Bioscience presents the CD40 antibody mitazalimab at the World Immunotherapy Congress 2020LSE:0RK9Alligator Bioscience Ab
2020/11/0516 : 49PR Newswire (US)Alligator Bioscience presents the CD40 antibody mitazalimab at the World Immunotherapy Congress 2020LSE:0RK9Alligator Bioscience Ab
2020/10/2722 : 18PR Newswire (US)Predicted therapeutic range dose levels reached in ATOR-1017 Phase ILSE:0RK9Alligator Bioscience Ab
2020/10/2722 : 16PR Newswire (US)Predicted therapeutic range dose levels reached in ATOR-1017 Phase ILSE:0RK9Alligator Bioscience Ab
2020/10/2215 : 30PR Newswire (US)Alligator Bioscience AB (publ): Interim report January-September 2020LSE:0RK9Alligator Bioscience Ab
2020/10/2215 : 28PR Newswire (US)Alligator Bioscience AB (publ): Interim report January-September 2020LSE:0RK9Alligator Bioscience Ab
2020/10/2214 : 25PR Newswire (US)Alligator Bioscience focuses on ATOR-1017 and mitazalimabLSE:0RK9Alligator Bioscience Ab
2020/10/2214 : 23PR Newswire (US)Alligator Bioscience focuses on ATOR-1017 and mitazalimabLSE:0RK9Alligator Bioscience Ab
2020/09/2820 : 25PR Newswire (US)Alligator Bioscience appoints Gayle Mills as Chief Business OfficerLSE:0RK9Alligator Bioscience Ab
2020/09/2820 : 24PR Newswire (US)Alligator Bioscience appoints Gayle Mills as Chief Business OfficerLSE:0RK9Alligator Bioscience Ab
2020/09/2500 : 00PR Newswire (US)Alligator Bioscience launches a new immuno-oncology conceptLSE:0RK9Alligator Bioscience Ab
2020/09/2423 : 58PR Newswire (US)Alligator Bioscience launches a new immuno-oncology conceptLSE:0RK9Alligator Bioscience Ab
2020/09/1615 : 40PR Newswire (US)Alligator Bioscience receives patent approval for the drug candidate ATOR-1015LSE:0RK9Alligator Bioscience Ab
2020/09/1615 : 39PR Newswire (US)Alligator Bioscience receives patent approval for the drug candidate ATOR-1015LSE:0RK9Alligator Bioscience Ab
2020/09/0921 : 19PR Newswire (US)Alligator Bioscience presents an update regarding the Phase I study with the drug candidate ATOR-1015LSE:0RK9Alligator Bioscience Ab
2020/09/0921 : 17PR Newswire (US)Alligator Bioscience presents an update regarding the Phase I study with the drug candidate ATOR-1015LSE:0RK9Alligator Bioscience Ab
2020/09/0415 : 42PR Newswire (US)Alligator Bioscience presents positive biomarker data demonstrating proof of mechanism in mitazalimab clinical Phase I studyLSE:0RK9Alligator Bioscience Ab
 Showing the most relevant articles for your search:LSE:0RK9

最近閲覧した銘柄

NASDAQ
NVDA
NVIDIA
USOTC
ADDYY
Adidas (QX)
COIN
BTCUSD
Bitcoin
NYSE
XOM
Exxon Mobil
NYSE
AXP
American Express
COIN
ETHUSD
Ethereum
NYSE
NKE
Nike
FX
USDEUR
US Dollar vs Euro
NYSE
KO
Coca Cola
FX
USDJPY
US Dollar vs Yen
PM
XAUUSD
Gold vs US Dollar
NYSE
MRK
Merck
NYSE
DIS
Walt Disney
AMEX
XLF
Financial Select Sector
CCOM
US500
US 500
NASDAQ
AAPL
Apple
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有